Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 99

1.

Influenza: emergence and control.

Lipatov AS, Govorkova EA, Webby RJ, Ozaki H, Peiris M, Guan Y, Poon L, Webster RG.

J Virol. 2004 Sep;78(17):8951-9. Review. No abstract available.

2.

Influenza: girding for disaster. Searching for all-powerful flu weapons.

Kaiser J.

Science. 2004 Oct 15;306(5695):395. No abstract available.

PMID:
15486268
3.

The clinical need for new antiviral drugs directed against influenza virus.

McCullers JA.

J Infect Dis. 2006 Mar 15;193(6):751-3. Epub 2006 Feb 13. No abstract available.

4.

Emerging influenza virus: a global threat.

Khanna M, Kumar P, Choudhary K, Kumar B, Vijayan VK.

J Biosci. 2008 Nov;33(4):475-82. Review.

5.

Antiviral therapy of influenza.

McCullers JA.

Expert Opin Investig Drugs. 2005 Mar;14(3):305-12. Review.

PMID:
15833061
6.

What the paediatrician needs to know when pandemic influenza arrives in clinical practice.

Ritz N, Curtis N.

Adv Exp Med Biol. 2008;609:164-84. doi: 10.1007/978-0-387-73960-1_13. Review. No abstract available.

PMID:
18193665
7.

Influenza vaccines: present and future.

Palese P, García-Sastre A.

J Clin Invest. 2002 Jul;110(1):9-13. Review. No abstract available.

8.

Vaccination strategies for an influenza pandemic.

Schwartz B, Gellin B.

J Infect Dis. 2005 Apr 15;191(8):1207-9. Epub 2005 Mar 14. No abstract available.

9.

Influenza: interspecies transmission and emergence of new pandemics.

Webster RG, Shortridge KF, Kawaoka Y.

FEMS Immunol Med Microbiol. 1997 Aug;18(4):275-9. Review. No abstract available.

10.

Novel strategies for prevention and treatment of influenza.

Kandel R, Hartshorn KL.

Expert Opin Ther Targets. 2005 Feb;9(1):1-22. Review.

PMID:
15757479
11.

Race against time.

Fauci AS.

Nature. 2005 May 26;435(7041):423-4. No abstract available.

PMID:
15917781
12.

[Vaccines and chemicals for the prevention of influenza].

Gendon IuZ.

Vopr Virusol. 2007 Jan-Feb;52(1):4-10. Review. Russian.

PMID:
17338227
13.

Meetings of the WHO working group on surveillance of influenza antiviral susceptibility – Geneva, November 2011 and June 2012.

[No authors listed]

Wkly Epidemiol Rec. 2012 Sep 28;87(39):369-74. English, French. No abstract available.

14.

Emergence of drug-resistant influenza virus: population dynamical considerations.

Regoes RR, Bonhoeffer S.

Science. 2006 Apr 21;312(5772):389-91.

PMID:
16627735
15.

Antiviral drugs for influenza.

[No authors listed]

Med Lett Drugs Ther. 2007 Oct 22;49(1272):85-6. Review. No abstract available.

PMID:
17938610
16.

Influenza: girding for disaster. Facing down pandemic flu, the world's defenses are weak.

Kaiser J.

Science. 2004 Oct 15;306(5695):394-7. No abstract available.

PMID:
15486267
17.

Flu factories.

Branswell H.

Sci Am. 2011 Jan;304(1):46-51. No abstract available.

PMID:
21265325
18.

Antiviral drugs for influenza.

[No authors listed]

Med Lett Drugs Ther. 2009 Nov 16;51(1325):89-92. Review. No abstract available.

PMID:
20220738
19.

New treatments for influenza.

Barik S.

BMC Med. 2012 Sep 13;10:104. doi: 10.1186/1741-7015-10-104. Review.

20.

Influenza pandemics and avian flu.

Fleming D.

BMJ. 2005 Nov 5;331(7524):1066-9. Review. No abstract available. Erratum in: BMJ. 2005 Nov 19;331(7526):1182.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk